Keryx Biopharma (KERX) Balance Sheet

Click line-items for a historical chart and %

Current assets:
Cash and cash equivalents
Short-term investment securities
Interest receivable
Other current assets	3.47M
Total current assets	159.95M
Property, plant and equipment, net	4.44M
Goodwill	3.21M
Other assets, net	1.02M
Total assets	168.63M
Current liabilities:
Accounts payable and accrued expenses	13.12M
Accrued compensation and related liabilities	4.92M
Deferred revenue	0
Total current liabilities	18.28M
Contingent equity rights
Other liabilities	1.18M
Total liabilities	146.64M
Stockholders' equity:
Preferred stock, $0.001 par value per share (5,000,000 shares authorized, no shares issued and outstanding)	0
Common stock, $0.001 par value per share (95,000,000 shares authorized, 69,771,035 and 61,521,483 shares issued, 69,691,087 and 61,441,535 shares outstanding at June 30, 2011 and December 31, 2010, respectively)	106K
Additional paid-in capital	823.55M
Treasury stock, at cost, 79,948 shares at June 30, 2011 and December 31, 2010, respectively	-357K
Accumulated deficit	-801.31M
Total stockholders' equity	21.99M
Total liabilities and stockholders' equity	168.63M

Entities mentioned with KERX